147 related articles for article (PubMed ID: 7123066)
1. Potency control of live, attenuated vaccines against measles used in children vaccinations in the State of São Paulo, Brazil [1976-1980].
Pral MM; Woe Fang FL; de Rizzo E
Rev Inst Med Trop Sao Paulo; 1982; 24(1):1-5. PubMed ID: 7123066
[No Abstract] [Full Text] [Related]
2. Vaccination against measles: a neverending story.
Stittelaar KJ; de Swart RL; Osterhaus AD
Expert Rev Vaccines; 2002 Aug; 1(2):151-9. PubMed ID: 12901554
[TBL] [Abstract][Full Text] [Related]
3. Measles vaccination: new strategies and formulations.
de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL
Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595
[TBL] [Abstract][Full Text] [Related]
4. Development of measles vaccines in Japan.
Ueda S
Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
[TBL] [Abstract][Full Text] [Related]
5. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
[No Abstract] [Full Text] [Related]
7. [The cell-mediated response after measles vaccination].
Pala S; Crimaldi G; Consolini R; Macchia P
Pediatr Med Chir; 1998; 20(3):213-6. PubMed ID: 9744016
[TBL] [Abstract][Full Text] [Related]
8. The value of potency testing of poliomyelitis and measles vaccines as an integral part of cold chain surveillance.
Saraswathy TS; Sinniah M; Lee WS; Lee PC
Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):265-8. PubMed ID: 8266228
[TBL] [Abstract][Full Text] [Related]
9. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
10. The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome.
Ahlgren C; Odén A; Haghighi S; Andersen O; Bergström T; Lycke J
J Neuroimmunol; 2011 Jun; 235(1-2):98-103. PubMed ID: 21550125
[TBL] [Abstract][Full Text] [Related]
11. [Current problems in measles. II. Measles vaccines--recent progress].
Ciufecu E
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):259-78. PubMed ID: 6438773
[No Abstract] [Full Text] [Related]
12. Will the current measles vaccines ever eradicate measles?
Stephenson J
Expert Rev Vaccines; 2002 Oct; 1(3):355-62. PubMed ID: 12901574
[TBL] [Abstract][Full Text] [Related]
13. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
[TBL] [Abstract][Full Text] [Related]
15. Attenuation and characterisation of Edmonston-Zagreb measles virus.
Ikić D; Juzbasić M; Beck M; Hrabar A; Cimbur-Schreiber T
Ann Immunol Hung; 1972; 16(0):175-81. PubMed ID: 4679646
[No Abstract] [Full Text] [Related]
16. [Studies of the live AMN USSR measles vaccine from the ESC strain and its use and problems of mass vaccinations against measles].
Czumakow MP; Woroszylowa MK; Graczew WP; Sinjak KM; Bojko WM; Sejbil WB; Rodin WI; Piwień GG
Przegl Epidemiol; 1970; 24(2):205-11. PubMed ID: 5431794
[No Abstract] [Full Text] [Related]
17. [Unsuitability of children revaccination against measles].
Bolotovskiĭ VM; Titova NS
Sov Med; 1981; (9):43-8. PubMed ID: 7313794
[No Abstract] [Full Text] [Related]
18. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
